IRIS
GIANNONI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.277
AS - Asia 13.015
EU - Europa 12.411
SA - Sud America 2.844
AF - Africa 335
Continente sconosciuto - Info sul continente non disponibili 318
OC - Oceania 31
Totale 53.231
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.695
SG - Singapore 4.726
RU - Federazione Russa 3.449
IT - Italia 3.247
CN - Cina 3.134
BR - Brasile 2.226
VN - Vietnam 1.801
GB - Regno Unito 1.778
CA - Canada 982
BD - Bangladesh 956
HK - Hong Kong 922
DE - Germania 841
UA - Ucraina 627
SE - Svezia 476
FR - Francia 441
IN - India 274
DK - Danimarca 271
FI - Finlandia 269
NL - Olanda 233
MX - Messico 230
AR - Argentina 223
IE - Irlanda 195
PL - Polonia 180
IL - Israele 178
TR - Turchia 159
ID - Indonesia 138
EC - Ecuador 128
ES - Italia 116
JP - Giappone 113
IQ - Iraq 109
PK - Pakistan 109
ZA - Sudafrica 105
AT - Austria 71
CO - Colombia 63
CR - Costa Rica 61
MA - Marocco 61
UZ - Uzbekistan 60
VE - Venezuela 58
HN - Honduras 49
LT - Lituania 43
AE - Emirati Arabi Uniti 42
CL - Cile 42
TT - Trinidad e Tobago 42
PH - Filippine 37
SV - El Salvador 37
GT - Guatemala 36
MY - Malesia 35
JM - Giamaica 33
PY - Paraguay 33
SA - Arabia Saudita 32
KE - Kenya 31
NI - Nicaragua 30
TN - Tunisia 28
EG - Egitto 27
EU - Europa 27
NP - Nepal 26
PR - Porto Rico 26
PE - Perù 25
UY - Uruguay 23
CH - Svizzera 21
RO - Romania 21
BE - Belgio 19
DZ - Algeria 18
AU - Australia 17
JO - Giordania 17
AZ - Azerbaigian 16
CW - ???statistics.table.value.countryCode.CW??? 16
TH - Thailandia 15
PT - Portogallo 14
BO - Bolivia 13
GP - Guadalupe 13
KG - Kirghizistan 13
KR - Corea 13
DO - Repubblica Dominicana 12
GR - Grecia 12
PS - Palestinian Territory 12
CZ - Repubblica Ceca 9
NZ - Nuova Zelanda 9
HU - Ungheria 8
PA - Panama 8
TW - Taiwan 8
BG - Bulgaria 7
ET - Etiopia 7
KZ - Kazakistan 7
LY - Libia 7
OM - Oman 7
SI - Slovenia 7
AO - Angola 6
BB - Barbados 6
BH - Bahrain 6
CI - Costa d'Avorio 6
GE - Georgia 6
GY - Guiana 6
IR - Iran 6
MD - Moldavia 6
MG - Madagascar 6
QA - Qatar 6
AL - Albania 5
CG - Congo 5
GD - Grenada 5
Totale 52.830
Salva come PNG Salva come JPEG
Città #
Dallas 3.748
Singapore 2.365
Ashburn 1.864
San Jose 1.702
Beijing 1.245
Council Bluffs 1.056
Southend 907
Hong Kong 802
Chandler 734
Los Angeles 695
Moscow 595
Fairfield 585
Houston 567
Ho Chi Minh City 535
Woodbridge 471
New York 466
Chicago 461
Milan 450
San Mateo 436
Ann Arbor 422
Falls Church 406
Seattle 376
Hanoi 364
Cambridge 334
Jacksonville 334
Rome 329
Wilmington 326
Santa Clara 323
The Dalles 304
Buffalo 269
Ottawa 261
São Paulo 249
Boardman 238
Lauterbourg 224
Phoenix 224
Hefei 215
Dearborn 214
Dublin 187
Pisa 185
Salt Lake City 184
Portsmouth 170
Stevenage 164
Beauharnois 163
Orem 158
Warsaw 155
Tel Aviv 152
Montreal 148
Dong Ket 147
Munich 146
London 142
Helsinki 141
Lawrence 133
Brooklyn 129
Atlanta 114
Mexico City 113
Toronto 112
Denver 103
Florence 99
Tokyo 99
Stockholm 91
Frankfurt am Main 88
Chennai 85
Poplar 85
Tampa 84
Naples 77
Elk Grove Village 75
Istanbul 75
Amsterdam 74
Da Nang 72
Montréal 72
Nuremberg 72
Johannesburg 71
Rio de Janeiro 71
San Diego 69
Figino 67
Bologna 62
Haiphong 61
Boston 60
Turin 58
Tashkent 55
Fremont 53
Columbus 52
San Francisco 52
Manchester 50
Guayaquil 49
Ankara 47
Washington 46
Brasília 44
Miami 44
San José 44
Biên Hòa 43
Mumbai 41
Turku 41
Lappeenranta 40
Redwood City 40
Belo Horizonte 39
Genoa 39
Charlotte 37
Dongguan 37
Paris 37
Totale 30.639
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.733
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 654
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 532
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 470
A simple echocardiographic score to rule out cardiac amyloidosis 433
A simple echocardiographic score to rule out cardiac amyloidosis 412
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 411
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 382
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 371
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 365
Central sleep apnea and cardiovascular disease state-of-the-art 362
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 362
[Central apneas and cardiovascular diseases] 358
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 357
Etiology, clinical presentation, and management of left main coronary artery aneurysms 354
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 350
Prediction of the chemoreflex gain by common clinical variables in heart failure 347
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 346
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 343
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 342
Treating chemoreflex in heart failure: modulation or demolition? 337
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 335
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 334
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 334
Adrenergic activation in heart failure: blockade or rebalance? 326
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 325
Eligibility for vericiguat in a real‐world, contemporary heart failure population 323
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 319
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 319
Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential 316
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 316
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 316
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 312
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 312
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 311
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 311
Screening the health status of people working in a university 305
How to take arms against central apneas in heart failure 301
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 301
Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure 299
Diaphragm function does not independently predict exercise intolerance in patients with precapillary pulmonary hypertension after adjustment for right ventricular function 296
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 294
Central And Obstructive Apneas in Heart Failure With Reduced, Mid-Range And Preserved Ejection Fraction. 294
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 293
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 291
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 288
A Novel Homozygous Mutation of the Desmoplakin Gene With Biventricular Arrhythmogenic Cardiomyopathy 288
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 283
APAP therapy does not improve impaired sleep quality and sympatho-vagal balance: a randomized trial in patients with obstructive sleep apnea and systolic heart failure 283
Contribution of the lung to the genesis of cheyne-stokes respiration in heart failure: Plant gain beyond chemoreflex gain and circulation time 283
Models of BOLD Signal Change in Breath Hold Studies and CO2 Challenges: Methodological Issues and Interpretation 281
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 280
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 280
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 280
Unveiling a sudden unexplained death case by whole exome sequencing and bioinformatic analysis 278
Effects of nasal high flow on sympathovagal balance, sleep, and sleep-related breathing in patients with precapillary pulmonary hypertension 277
Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan 276
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones 274
Improved survival in limited scleroderma-related pulmonary artery hypertension 274
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 272
A Novel Workflow for Electrophysiology Studies in Patients with Brugada Syndrome 271
Valve disease in cardiac amyloidosis: an echocardiographic score 271
B-type natriuretic peptide secretion following scuba diving 271
Correlational analysis of electroencephalographic and end-tidal carbon dioxide signals during breath-hold exercise 270
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease 270
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register 268
Prognostic value of right ventricular refractory period heterogeneity in Type-1 Brugada electrocardiographic pattern 267
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 265
Chemoreflex and Baroreflex Sensitivity Hold a Strong Prognostic Value in Chronic Heart Failure 263
A scoping review of machine learning models to predict risk of falls in elders, without using sensor data 261
Mapping dependencies of BOLD signal change to end-tidal CO2: Linear and nonlinear modeling, and effect of physiological noise correction 261
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 260
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 260
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 259
In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation 259
null 258
An atypical case of cardiac amyloidosis. 258
null 258
Renin profiling predicts neurohormonal response to sacubitril/valsartan 258
Autonomic and respiratory consequences of altered chemoreflex function: clinical and therapeutic implications in cardiovascular diseases 256
Role of Imaging in Cardiomyopathies 255
Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients. 255
Heart Failure Results in Inspiratory Muscle Dysfunction Irrespective of Left Ventricular Ejection Fraction 255
Effects of hyperventilation length on muscle sympathetic nerve activity in healthy humans simulating periodic breathing 255
Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure. 253
null 253
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? 253
Changes in chemoreflex characteristics following acetazolamide administration in patients with chronic heart failure and Cheyne Stokes respiration 251
High-risk NSTEMI due to subclavian artery atherothrombosis in a prior coronary artery bypass graft patient 251
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction 251
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea 250
Inspiratory muscle dysfunction and restrictive lung function impairment in congenital heart disease: Association with immune inflammatory response and exercise intolerance 249
Ld-EEG Effective Brain Connectivity in Patients With Cheyne-Stokes Respiration 248
Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry 247
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 246
Impact of Simulated Hyperventilation and Periodic Breathing on Sympatho-Vagal Balance and Hemodynamics in Patients with and without Heart Failure 245
On the Use of Linear-Modelling-based Algorithms for Physiological Noise Correction in fMRI Studies of the Central Breathing Control 243
Inferior Vena Cava Edge Tracking Echocardiography: A Promising Tool with Applications in Multiple Clinical Settings 243
Cardiac Amyloidosis: How Its Epidemiology is Changing 242
Sex-specific associations of myocardial perfusion imaging with outcomes in patients with suspected chronic coronary syndrome 240
Totale 31.550
Salva come PNG Salva come JPEG
Categoria #
all - tutte 260.143
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 260.143
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.686 0 0 0 278 71 43 239 431 151 247 55 171
2022/20231.643 133 154 83 209 220 243 17 143 253 32 81 75
2023/20241.162 107 34 280 90 37 88 80 49 30 39 39 289
2024/202510.624 65 80 466 207 596 585 1.383 2.351 871 919 1.973 1.128
2025/202625.926 1.343 3.988 2.900 3.612 2.928 1.598 2.381 1.034 1.384 1.546 1.706 1.506
2026/20274.599 752 799 1.458 1.590 0 0 0 0 0 0 0 0
Totale 53.231